Canasa and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Canasa (mesalamine) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include crohn's disease among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Canasa and Cipro. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Canasa?

Canasa has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 1,676 Canasa users. Check the latest studies of Canasa.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.



On Jul, 16, 2026

15 people who take Canasa and Cipro together, and have interactions are studied.

Canasa and Cipro drug interactions.

What are the common drug interactions of Canasa and Cipro, by gender? *:

female:

  1. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  2. Asthenia (weakness)
  3. Benign breast neoplasm (benign (non-cancerous) tumours of the breast)
  4. Blood bilirubin increased
  5. Blood thyroid stimulating hormone decreased
  6. Breast disorder female
  7. Carotid artery stenosis (narrowing of carotid artery)
  8. Chest pain
  9. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

male:

  1. Fatigue (feeling of tiredness)

What are the common drug interactions of Canasa and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Erythema (redness of the skin)
  2. Abdominal pain lower
  3. Enteritis (inflammation of the small intestine)
  4. Inflammation
  5. Nausea (feeling of having an urge to vomit)
  6. Small intestinal obstruction (blockage in small intestine)
  7. Vomiting

30-39:

  1. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  2. Pigmentation disorder (disturbances of human skin colour)
  3. Pleural infection (infection of membrane of lungs)
  4. Pyrexia (fever)
  5. Rash
  6. Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
  7. Skin lesion
  8. Temperature intolerance (inability to go in temperature)
  9. Vision blurred
  10. Anxiety

40-49:

  1. Fatigue (feeling of tiredness)

50-59:

  1. Anaemia (lack of blood)
  2. Angina pectoris (chest pain due to ischemia of the heart muscle)
  3. Anxiety
  4. Aphasia (damage to the parts of the brain that control language)
  5. Arthralgia (joint pain)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Back pain
  8. Blood chloride decreased
  9. Blood glucose increased
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

60+:

  1. Asthenia (weakness)
  2. Benign breast neoplasm (benign (non-cancerous) tumours of the breast)
  3. Drug resistance (reduction in effectiveness of a drug)
  4. Ear infection
  5. Emotional distress
  6. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  7. Eustachian tube dysfunction (eustachian tube problems like clearing the ears when flying, suffering infection, and recurring ear infection)
  8. Excoriation (to tear or wear off the skin of)
  9. Gastrointestinal tract irritation
  10. Headache (pain in head)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 10 people, 66.67%
  2. Vitamin D Decreased: 1 person, 6.67%
  3. High Blood Cholesterol: 1 person, 6.67%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%
  5. Bone Disorder: 1 person, 6.67%
  6. Breast Cancer: 1 person, 6.67%
  7. Dry Eyes (lack of adequate tears): 1 person, 6.67%
  8. Ear Congestion: 1 person, 6.67%
  9. Ear Pain: 1 person, 6.67%
  10. Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Canasa and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Canasa and Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Canasa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Canasa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mesalamine and ciprofloxacin hydrochloride (the active ingredients of Canasa and Cipro, respectively), and Canasa and Cipro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: